These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38759772)

  • 21. A high-risk carbapenem-resistant Pseudomonas aeruginosa clone detected in red deer (Cervus elaphus) from Portugal.
    Torres RT; Cunha MV; Ferreira H; Fonseca C; Palmeira JD
    Sci Total Environ; 2022 Jul; 829():154699. PubMed ID: 35318052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of imipenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Burns Hospital in Tunisia: detection of a novel class 1 integron.
    Chairat S; Ben Yahia H; Rojo-Bezares B; Sáenz Y; Torres C; Ben Slama K
    J Chemother; 2019 May; 31(3):120-126. PubMed ID: 30849001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic characteristics of multidrug-resistant Pseudomonas aeruginosa from hospital wastewater treatment plant in Rio de Janeiro, Brazil.
    Miranda CC; de Filippis I; Pinto LH; Coelho-Souza T; Bianco K; Cacci LC; Picão RC; Clementino MM
    J Appl Microbiol; 2015 Jun; 118(6):1276-86. PubMed ID: 25752460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence and spread of VIM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates in Japan.
    Hishinuma T; Uchida H; Tohya M; Shimojima M; Tada T; Kirikae T
    J Glob Antimicrob Resist; 2020 Dec; 23():265-268. PubMed ID: 33045441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem-resistant Pseudomonas aeruginosa carrying bla
    Neves PR; Perdigão Neto LV; Ruedas Martins RC; Ramos JF; Leite G; Rossi F; Sanabani SS; Rocha V; Batista MV; Guimaraes T; Levin AS; Costa SF
    J Glob Antimicrob Resist; 2019 Mar; 16():92-97. PubMed ID: 30244038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance
    Qader GM; Jarjees KK; Jarjees RK
    J Med Life; 2022 Sep; 15(9):1105-1109. PubMed ID: 36415531
    [No Abstract]   [Full Text] [Related]  

  • 27. Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
    Lasarte-Monterrubio C; Fraile-Ribot PA; Vázquez-Ucha JC; Cabot G; Guijarro-Sánchez P; Alonso-García I; Rumbo-Feal S; Galán-Sánchez F; Beceiro A; Arca-Suárez J; Oliver A; Bou G
    J Antimicrob Chemother; 2022 Sep; 77(10):2809-2815. PubMed ID: 35904000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
    Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S
    Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.
    O'Neall D; Juhász E; Tóth Á; Urbán E; Szabó J; Melegh S; Katona K; Kristóf K
    Acta Microbiol Immunol Hung; 2020 Mar; 67(1):61-65. PubMed ID: 32208923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of
    Arfaoui A; Rojo-Bezares B; Fethi M; López M; Toledano P; Sayem N; Ben Khelifa Melki S; Ouzari HI; Klibi N; Sáenz Y
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38963417
    [No Abstract]   [Full Text] [Related]  

  • 31. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Int J Antimicrob Agents; 2017 Jun; 49(6):767-769. PubMed ID: 28392440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
    Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil.
    de Oliveira Santos IC; Albano RM; Asensi MD; D'Alincourt Carvalho-Assef AP
    J Glob Antimicrob Resist; 2018 Dec; 15():99-100. PubMed ID: 30172833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic analysis of a Pseudomonas aeruginosa strain harbouring bla
    Valiatti TB; Streling AP; Cayô R; Santos FF; Almeida MS; Tonini MAL; Gales AC
    J Glob Antimicrob Resist; 2024 Jun; 37():69-71. PubMed ID: 38428456
    [No Abstract]   [Full Text] [Related]  

  • 35. Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica.
    Toval F; Guzmán-Marte A; Madriz V; Somogyi T; Rodríguez C; García F
    J Med Microbiol; 2015 Jan; 64(Pt 1):37-43. PubMed ID: 25355933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluated gene expressions of Metallo beta lactamase genes GIM and , VIM, SPM in Pseudomonas aeruginosa clinical isolates.
    Ali MG; Almoneim ZA; Kareem SM
    Mol Biol Rep; 2023 Dec; 50(12):10111-10120. PubMed ID: 37917414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
    Liakopoulos A; Mavroidi A; Katsifas EA; Theodosiou A; Karagouni AD; Miriagou V; Petinaki E
    BMC Infect Dis; 2013 Oct; 13():505. PubMed ID: 24168643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
    Del Barrio-Tofiño E; López-Causapé C; Oliver A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiogram profile and virulence signatures of Pseudomonas aeruginosa isolates recovered from selected agrestic hospital effluents.
    Mapipa Q; Digban TO; Nnolim NE; Nwodo UU
    Sci Rep; 2021 Jun; 11(1):11800. PubMed ID: 34083705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic Resistance Determinants and Virulence Factors of Hypervirulent and Carbapenem Non-Susceptible Pseudomonas aeruginosa.
    Zhu JM; Jiang RJ; Wu JL; Weng XB; Ling LP
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.